Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Maravai LifeSciences Holdings, Inc. - Class A common stock
(NQ:
MRVI
)
4.200
+0.080 (+1.94%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Maravai LifeSciences Holdings, Inc. - Class A common stock
< Previous
1
2
3
4
5
6
7
8
Next >
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
May 13, 2024
From
TriLink BioTechnologies
Via
Business Wire
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
May 09, 2024
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Where Maravai LifeSciences Stands With Analysts
May 09, 2024
Via
Benzinga
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript
May 09, 2024
MRVI earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Maravai LifeSciences Q4 Earnings
February 22, 2024
Via
Benzinga
MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
MRVI stock results show that Maravai LifeSciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Maravai LifeSciences Reports First Quarter 2024 Financial Results
May 08, 2024
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
April 30, 2024
From
TriLink BioTechnologies
Via
Business Wire
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
April 18, 2024
From
TriLink BioTechnologies
Via
Business Wire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
April 10, 2024
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
April 09, 2024
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
April 04, 2024
Via
AB Newswire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
March 12, 2024
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
March 08, 2024
Via
AB Newswire
Exposures
Product Safety
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
February 28, 2024
Via
AB Newswire
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
February 26, 2024
Via
AB Newswire
Nasdaq Edges Lower; AXT Shares Surge After Q4 Results
February 23, 2024
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.2% on Friday. The Dow traded up 0.23% to 39,158.52 while the NASDAQ fell 0.19% to 16,011.27. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Small-Cap Maravai LifeSciences' Q4 Outperforms Expectations, Analyst shows Optimism Around 2024 Guidance
February 23, 2024
Maravai LifeSciences impresses with Q4 2023 revenue of $74.1 million, surpassing estimates. CEO Trey Martin highlights strong execution, cost reductions, and a 28% adjusted EBITDA margin. 2024 revenue...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 23, 2024
Via
Benzinga
Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher
February 23, 2024
U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The Dow traded up 0.36% to 39,209.32 while the NASDAQ rose 0.01% to 16,042.80....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 23, 2024
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.
Via
Benzinga
Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
February 23, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings
February 23, 2024
U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket
February 23, 2024
Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 23, 2024
Via
Benzinga
Nasdaq, S&P 500 Set for Mixed Open After Nvidia Euphoria: Analyst Picks Major Market Catalyst This Year If There Are No Rate Cuts
February 23, 2024
After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday reflects edginess.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
February 23, 2024
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript
February 22, 2024
MRVI earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's After-Market Session
February 22, 2024
Via
Benzinga
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
February 22, 2024
Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.